CN1853654A - 一种含有珍珠和维生素的口服制剂 - Google Patents
一种含有珍珠和维生素的口服制剂 Download PDFInfo
- Publication number
- CN1853654A CN1853654A CNA2005100497119A CN200510049711A CN1853654A CN 1853654 A CN1853654 A CN 1853654A CN A2005100497119 A CNA2005100497119 A CN A2005100497119A CN 200510049711 A CN200510049711 A CN 200510049711A CN 1853654 A CN1853654 A CN 1853654A
- Authority
- CN
- China
- Prior art keywords
- vitamin
- mass fractions
- mass
- margarita
- fractions
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000011782 vitamin Substances 0.000 title claims abstract description 39
- 238000002360 preparation method Methods 0.000 title description 4
- WIGIZIANZCJQQY-UHFFFAOYSA-N 4-ethyl-3-methyl-N-[2-[4-[[[(4-methylcyclohexyl)amino]-oxomethyl]sulfamoyl]phenyl]ethyl]-5-oxo-2H-pyrrole-1-carboxamide Chemical compound O=C1C(CC)=C(C)CN1C(=O)NCCC1=CC=C(S(=O)(=O)NC(=O)NC2CCC(C)CC2)C=C1 WIGIZIANZCJQQY-UHFFFAOYSA-N 0.000 title 1
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 claims abstract description 62
- 239000000843 powder Substances 0.000 claims abstract description 41
- 229940088594 vitamin Drugs 0.000 claims abstract description 38
- 229930003231 vitamin Natural products 0.000 claims abstract description 38
- 235000013343 vitamin Nutrition 0.000 claims abstract description 38
- 239000011790 ferrous sulphate Substances 0.000 claims abstract description 32
- 235000003891 ferrous sulphate Nutrition 0.000 claims abstract description 32
- BAUYGSIQEAFULO-UHFFFAOYSA-L iron(2+) sulfate (anhydrous) Chemical compound [Fe+2].[O-]S([O-])(=O)=O BAUYGSIQEAFULO-UHFFFAOYSA-L 0.000 claims abstract description 32
- 229910000359 iron(II) sulfate Inorganic materials 0.000 claims abstract description 32
- NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 claims abstract description 32
- 229960001763 zinc sulfate Drugs 0.000 claims abstract description 32
- 229910000368 zinc sulfate Inorganic materials 0.000 claims abstract description 32
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims abstract description 31
- 235000019359 magnesium stearate Nutrition 0.000 claims abstract description 31
- 239000000741 silica gel Substances 0.000 claims abstract description 31
- 229910002027 silica gel Inorganic materials 0.000 claims abstract description 31
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims abstract description 29
- 239000008101 lactose Substances 0.000 claims abstract description 29
- 235000005956 Cosmos caudatus Nutrition 0.000 claims description 91
- 244000293323 Cosmos caudatus Species 0.000 claims description 91
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 68
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 64
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 claims description 34
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 claims description 34
- 229930003427 Vitamin E Natural products 0.000 claims description 34
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 claims description 34
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims description 34
- 235000019155 vitamin A Nutrition 0.000 claims description 34
- 239000011719 vitamin A Substances 0.000 claims description 34
- 235000019165 vitamin E Nutrition 0.000 claims description 34
- 239000011709 vitamin E Substances 0.000 claims description 34
- 229940046009 vitamin E Drugs 0.000 claims description 34
- 229940045997 vitamin a Drugs 0.000 claims description 34
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims description 32
- 229930003268 Vitamin C Natural products 0.000 claims description 32
- -1 hydroxypropyl Chemical group 0.000 claims description 32
- 235000019154 vitamin C Nutrition 0.000 claims description 32
- 239000011718 vitamin C Substances 0.000 claims description 32
- 101800002326 Adipokinetic hormone Proteins 0.000 claims description 31
- 229930003316 Vitamin D Natural products 0.000 claims description 31
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 claims description 31
- 235000019166 vitamin D Nutrition 0.000 claims description 31
- 239000011710 vitamin D Substances 0.000 claims description 31
- 150000003710 vitamin D derivatives Chemical class 0.000 claims description 31
- 229940046008 vitamin d Drugs 0.000 claims description 31
- 239000000203 mixture Substances 0.000 claims description 30
- 150000003722 vitamin derivatives Chemical class 0.000 claims description 27
- 238000009472 formulation Methods 0.000 claims description 22
- 239000003826 tablet Substances 0.000 claims description 18
- 239000002775 capsule Substances 0.000 claims description 10
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 claims description 8
- 239000000600 sorbitol Substances 0.000 claims description 8
- 239000007910 chewable tablet Substances 0.000 claims description 4
- 229940068682 chewable tablet Drugs 0.000 claims description 4
- 239000002552 dosage form Substances 0.000 claims description 2
- 239000007935 oral tablet Substances 0.000 claims description 2
- 229940096978 oral tablet Drugs 0.000 claims description 2
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 abstract description 15
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 abstract description 15
- 208000001132 Osteoporosis Diseases 0.000 abstract description 6
- 239000003814 drug Substances 0.000 abstract description 6
- 238000007254 oxidation reaction Methods 0.000 abstract description 4
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 abstract 1
- DFPAKSUCGFBDDF-ZQBYOMGUSA-N [14c]-nicotinamide Chemical compound N[14C](=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-ZQBYOMGUSA-N 0.000 abstract 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 abstract 1
- 229960001231 choline Drugs 0.000 abstract 1
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 abstract 1
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 abstract 1
- 230000001502 supplementing effect Effects 0.000 abstract 1
- 239000008187 granular material Substances 0.000 description 36
- 239000011575 calcium Substances 0.000 description 18
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 17
- 229910052791 calcium Inorganic materials 0.000 description 16
- 241000700159 Rattus Species 0.000 description 15
- 238000002156 mixing Methods 0.000 description 14
- 239000007779 soft material Substances 0.000 description 14
- 206010013786 Dry skin Diseases 0.000 description 13
- 238000001035 drying Methods 0.000 description 13
- 230000000694 effects Effects 0.000 description 11
- 210000000689 upper leg Anatomy 0.000 description 10
- 230000003203 everyday effect Effects 0.000 description 9
- 238000002474 experimental method Methods 0.000 description 5
- 230000002265 prevention Effects 0.000 description 5
- 210000004369 blood Anatomy 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 235000021590 normal diet Nutrition 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- 230000037396 body weight Effects 0.000 description 3
- 210000000988 bone and bone Anatomy 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- 230000003647 oxidation Effects 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 2
- 102000003992 Peroxidases Human genes 0.000 description 2
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 2
- 239000002671 adjuvant Substances 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 239000000470 constituent Substances 0.000 description 2
- 238000001739 density measurement Methods 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 230000037356 lipid metabolism Effects 0.000 description 2
- 239000002398 materia medica Substances 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 230000008558 metabolic pathway by substance Effects 0.000 description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
- 108040007629 peroxidase activity proteins Proteins 0.000 description 2
- 230000035790 physiological processes and functions Effects 0.000 description 2
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 239000011701 zinc Substances 0.000 description 2
- 229910052725 zinc Inorganic materials 0.000 description 2
- 102000016893 Amine Oxidase (Copper-Containing) Human genes 0.000 description 1
- 108010028700 Amine Oxidase (Copper-Containing) Proteins 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 102000018832 Cytochromes Human genes 0.000 description 1
- 108010052832 Cytochromes Proteins 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- 241000201295 Euphrasia Species 0.000 description 1
- WSMYVTOQOOLQHP-UHFFFAOYSA-N Malondialdehyde Chemical compound O=CCC=O WSMYVTOQOOLQHP-UHFFFAOYSA-N 0.000 description 1
- 102000036675 Myoglobin Human genes 0.000 description 1
- 108010062374 Myoglobin Proteins 0.000 description 1
- BAWFJGJZGIEFAR-NNYOXOHSSA-N NAD zwitterion Chemical compound NC(=O)C1=CC=C[N+]([C@H]2[C@@H]([C@H](O)[C@@H](COP([O-])(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 BAWFJGJZGIEFAR-NNYOXOHSSA-N 0.000 description 1
- 241000475481 Nebula Species 0.000 description 1
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- OUUQCZGPVNCOIJ-UHFFFAOYSA-M Superoxide Chemical class [O-][O] OUUQCZGPVNCOIJ-UHFFFAOYSA-M 0.000 description 1
- 229930003451 Vitamin B1 Natural products 0.000 description 1
- 229930003779 Vitamin B12 Natural products 0.000 description 1
- 229930003471 Vitamin B2 Natural products 0.000 description 1
- 229930003448 Vitamin K Natural products 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 210000000709 aorta Anatomy 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000037182 bone density Effects 0.000 description 1
- 150000001669 calcium Chemical class 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 230000004098 cellular respiration Effects 0.000 description 1
- FDJOLVPMNUYSCM-WZHZPDAFSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+3].N#[C-].N([C@@H]([C@]1(C)[N-]\C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C(\C)/C1=N/C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C\C1=N\C([C@H](C1(C)C)CCC(N)=O)=C/1C)[C@@H]2CC(N)=O)=C\1[C@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]1[C@@H](O)[C@@H](N2C3=CC(C)=C(C)C=C3N=C2)O[C@@H]1CO FDJOLVPMNUYSCM-WZHZPDAFSA-L 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- JEIPFZHSYJVQDO-UHFFFAOYSA-N ferric oxide Chemical compound O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 1
- 235000003969 glutathione Nutrition 0.000 description 1
- 229960003180 glutathione Drugs 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 229960001340 histamine Drugs 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 230000003212 lipotrophic effect Effects 0.000 description 1
- 210000005229 liver cell Anatomy 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 229950006238 nadide Drugs 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 150000002978 peroxides Chemical class 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 description 1
- 210000002381 plasma Anatomy 0.000 description 1
- 210000002706 plastid Anatomy 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 150000004032 porphyrins Chemical class 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 235000019163 vitamin B12 Nutrition 0.000 description 1
- 239000011715 vitamin B12 Substances 0.000 description 1
- 235000019164 vitamin B2 Nutrition 0.000 description 1
- 239000011716 vitamin B2 Substances 0.000 description 1
- 235000019160 vitamin B3 Nutrition 0.000 description 1
- 239000011708 vitamin B3 Substances 0.000 description 1
- 235000019158 vitamin B6 Nutrition 0.000 description 1
- 239000011726 vitamin B6 Substances 0.000 description 1
- 235000019168 vitamin K Nutrition 0.000 description 1
- 239000011712 vitamin K Substances 0.000 description 1
- 150000003721 vitamin K derivatives Chemical class 0.000 description 1
- 229940011671 vitamin b6 Drugs 0.000 description 1
- 229940046010 vitamin k Drugs 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
组别 | 数量 | BMD(g/cm2) |
1 | 10 | 0.0986±0.0005* |
2 | 10 | 0.1321±0.0004* |
3 | 10 | 0.1719±0.0005** |
组别 | 数量 | Ca(mg/g) |
1 | 10 | 96.5±0.36* |
2 | 10 | 115.5±0.61* |
3 | 10 | 151.4±0.68** |
MDA | 1 | 140 | 144 | 136 | 135 | 140 | 147 | 139 | 142 | 139 | 141 |
2 | 126 | 130 | 128 | 131 | 129 | 121 | 122 | 124 | 120 | 120 | |
3 | 131 | 130 | 129 | 129 | 129 | 128 | 134 | 131 | 130 | 132 | |
4 | 120 | 119 | 117 | 119 | 121 | 123 | 125 | 115 | 117 | 119 | |
5 | 118 | 110 | 116 | 121 | 120 | 120 | 117 | 114 | 113 | 111 |
组别 | 数量 | SOD(UN/ml) | MDA(nmol/ml) | GSH-Px |
1 | 10 | 112.5±0.6* | 12.5±0.5* | 140±3.5* |
2 | 10 | 82.3±0.5* | 7.6±0.4* | 125±4.3* |
3 | 10 | 88.4±0.6* | 8.3±0.4* | 130±1.8* |
4 | 10 | 93.4±0.6* | 6.4±0.3* | 119±2.9* |
5 | 10 | 70.1±0.6** | 4.3±0.3** | 116±3.9** |
组别 | 数量 | BMD(g/cm2) |
高含量组 | 10 | 0.1285±0.0402* |
中含量组 | 10 | 0.1716±0.0010** |
低含量组 | 10 | 0.1319±0.0006* |
纯珍珠组 | 10 | 0.1221±0.0038* |
空白组 | 10 | 0.0959±0.0042* |
组别 | 数量 | Ca(mg/g) |
高含量组 | 10 | 120.46±0.52* |
中含量组 | 10 | 156.27±0.18** |
低含量组 | 10 | 114.09±0.24* |
纯珍珠组 | 10 | 117.32±0.39* |
空白组 | 10 | 97.47±0.28* |
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN200510049711A CN1853654B (zh) | 2005-04-29 | 2005-04-29 | 一种含有珍珠和维生素的口服制剂 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN200510049711A CN1853654B (zh) | 2005-04-29 | 2005-04-29 | 一种含有珍珠和维生素的口服制剂 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1853654A true CN1853654A (zh) | 2006-11-01 |
CN1853654B CN1853654B (zh) | 2010-05-26 |
Family
ID=37194308
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN200510049711A Expired - Fee Related CN1853654B (zh) | 2005-04-29 | 2005-04-29 | 一种含有珍珠和维生素的口服制剂 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1853654B (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102824368A (zh) * | 2012-09-03 | 2012-12-19 | 孙培雄 | 一种珍珠维生素c片剂及其制作方法 |
CN104489830A (zh) * | 2014-11-28 | 2015-04-08 | 东莞市青麦田数码科技有限公司 | 一种用于防治口腔溃疡的营养液 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1135973C (zh) * | 1999-01-18 | 2004-01-28 | 倪荣聪 | 蛋氨酸组合物在制备治疗心、脑血管疾病的药物中的应用 |
CN1171594C (zh) * | 2000-07-21 | 2004-10-20 | 北京本元青阳生物科技发展有限公司 | 含珍珠粉和抗坏血酸的组合物 |
CN1157195C (zh) * | 2000-10-31 | 2004-07-14 | 上海雷允上药业有限公司 | 一种复方超细珍珠粉软胶囊及制备方法 |
CN1436539A (zh) * | 2002-02-06 | 2003-08-20 | 李福康 | 高效铁锌钙补血补钙保健品及其制备方法 |
-
2005
- 2005-04-29 CN CN200510049711A patent/CN1853654B/zh not_active Expired - Fee Related
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102824368A (zh) * | 2012-09-03 | 2012-12-19 | 孙培雄 | 一种珍珠维生素c片剂及其制作方法 |
CN102824368B (zh) * | 2012-09-03 | 2014-11-05 | 孙培雄 | 一种珍珠维生素c片剂及其制作方法 |
CN104489830A (zh) * | 2014-11-28 | 2015-04-08 | 东莞市青麦田数码科技有限公司 | 一种用于防治口腔溃疡的营养液 |
CN104489830B (zh) * | 2014-11-28 | 2016-06-01 | 东莞市莞信企业管理咨询有限公司 | 一种用于防治口腔溃疡的营养液 |
Also Published As
Publication number | Publication date |
---|---|
CN1853654B (zh) | 2010-05-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1279900C (zh) | 用于睡眠障碍的加巴喷丁类似物 | |
CN1087517A (zh) | 用于降低高半胱氨酸水平的药物制剂 | |
CN1929821A (zh) | 包含匹莫苯的药物组合物 | |
CN1596103A (zh) | 用于治疗ii型糖尿病、包含二甲双胍和格列本脲的药物组合物 | |
CN1518442A (zh) | 含有环孢菌素的药物组合物 | |
CN1096627A (zh) | 稳定乳牛高牛乳产率的日粮及获得稳定的高产牛乳的饲养方法 | |
CN1915222A (zh) | 一种脂质体组合物及其制备方法 | |
CN1159004C (zh) | 具有高含量n-乙酰半胱氨酸的可吞咽片剂 | |
CN1146414C (zh) | 氨基酸组合物及其在免疫抑制中的用途 | |
CN1168104A (zh) | 皮肤炎治疗剂 | |
CN1148175C (zh) | L-苏糖酸钙预防、抑制和治疗骨质疏松和佝偻病的用途 | |
CN1927312A (zh) | 一种含有葡萄提取物的药物组合物及其制备方法、用途 | |
CN1853654A (zh) | 一种含有珍珠和维生素的口服制剂 | |
CN1616014A (zh) | 一种治疗糖尿病的中药组合物及其制备方法 | |
CN1518989A (zh) | 海狗油软胶囊及其在制备调节血脂保健品中的应用 | |
CN1679807A (zh) | 一种清热通淋的中药制剂及其制备方法 | |
CN1901926A (zh) | 含有葫芦科植物提取物或者从其中分离的具有抗脂肪形成和抗肥胖症活性的纯化提取物的组合物 | |
CN1087171C (zh) | 适合中国人的多种维生素和矿物质/微量元素复合制剂 | |
CN1480134A (zh) | 氨基酸碘组合物及其制备方法和应用 | |
CN1895263A (zh) | 牛磺酸在制备含有葛根素的注射剂中的应用 | |
CN1857288A (zh) | 一种复方甘草酸及其盐的缓释制剂及其制备方法 | |
CN1557352A (zh) | 菊苣水提取物的新用途 | |
CN1212842C (zh) | 美他多辛咀嚼片及其制备方法 | |
CN1709498A (zh) | 一种参芪降糖软胶囊及其制备检测方法 | |
CN1169523C (zh) | 枸橼酸他莫昔芬缓释片 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CP01 | Change in the name or title of a patent holder | ||
CP01 | Change in the name or title of a patent holder |
Address after: 311804 Zhejiang, Zhuji City Industrial Park under the lake Patentee after: PURE PEARL GROUP Co.,Ltd. Address before: 311804 Zhejiang, Zhuji City Industrial Park under the lake Patentee before: Zhejiang Shanxiahu Pearl Group Co.,Ltd. |
|
CP03 | Change of name, title or address | ||
CP03 | Change of name, title or address |
Address after: Hu Zhen Zheng Jia Hu Cun 311804 Zhejiang city of Zhuji Province under the mountain Patentee after: Innovative healthcare management Limited by Share Ltd. Address before: 311804 Zhejiang, Zhuji City Industrial Park under the lake Patentee before: PURE PEARL GROUP Co.,Ltd. |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20170309 Address after: 311804 Zhejiang city of Zhuji Province Pearl Characteristic Industrial Park Patentee after: Zhejiang Yinggelai Pharmacy Co.,Ltd. Address before: Hu Zhen Zheng Jia Hu Cun 311804 Zhejiang city of Zhuji Province under the mountain Patentee before: Innovative healthcare management Limited by Share Ltd. |
|
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20100526 Termination date: 20180429 |